{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:52:25Z","timestamp":1774608745545,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jid.2017.10.029","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T05:18:03Z","timestamp":1510291083000},"page":"864-871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis"],"prefix":"10.1016","volume":"138","author":[{"given":"Jessica M.","family":"Fuhriman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e5rten C.G.","family":"Winge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Haberstock-Debic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Oliver","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Peter","family":"Marinkovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.10.029_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2017.10.029_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1203475416651605","article-title":"The role of IL-17 in the pathogenesis of psoriasis and update on IL-17 inhibitors for the treatment of plaque psoriasis","volume":"20","author":"AbuHilal","year":"2016","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.jid.2017.10.029_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2012.12.004","article-title":"Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-\u03baB and STAT3 in human keratinocytes","volume":"70","author":"Andr\u00e9s","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jid.2017.10.029_bib4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.immunol.22.012703.104743","article-title":"TEC family kinases in T lymphocyte development and function","volume":"23","author":"Berg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2017.10.029_bib5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2017.10.029_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1590\/abd1806-4841.20165080","article-title":"Psoriasis comorbidities: complications and benefits of immunobiological treatment","volume":"91","author":"Carvalho","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib7","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.1501828","article-title":"A\u00a0small molecule inhibitor of ITK and RLK impairs Th1 differentiation and prevents colitis disease progression","volume":"195","author":"Cho","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.10.029_bib8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","article-title":"Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis","volume":"32","author":"Durant","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2017.10.029_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.10.029_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumor necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2017.10.029_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.12.9.1085","article-title":"Targeting tumor necrosis factor alpha in psoriasis and psoriatic arthritis","volume":"12","author":"Fantuzzi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jid.2017.10.029_bib13","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1073\/pnas.0808459106","article-title":"Tec kinase ITK in \u03b3\u03b4T cells is pivotal for controlling IgE production in\u00a0vivo","volume":"104","author":"Felices","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2017.10.029_bib14","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur J Immunol"},{"issue":"9583","key":"10.1016\/j.jid.2017.10.029_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2017.10.029_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2017.10.029_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1067\/mjd.2000.107945","article-title":"Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study","volume":"43","author":"Gottlieb","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jid.2017.10.029_bib19","first-page":"e44","article-title":"Psoriasis treatment patterns: phototherapy, oral nonbiologic, and biological therapies","volume":"7","author":"Kimball","year":"2015","journal-title":"Am J Pharm Benefits"},{"key":"10.1016\/j.jid.2017.10.029_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.10.029_bib22","first-page":"115","article-title":"Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis","volume":"11","author":"Mussi","year":"1997","journal-title":"J\u00a0Biol Regul Homeost Agents"},{"key":"10.1016\/j.jid.2017.10.029_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","article-title":"Genomewide scan reveals association of psoriasis with IL-23 and NF-kB pathways","volume":"41","author":"Nair","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2017.10.029_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2017.10.029_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.10.029_bib26","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiatie psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2017.10.029_bib27","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2017.10.029_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jid.2017.10.029_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood-2008-12-196345","article-title":"Enhanced development of CD4+ \u03b3\u03b4 T cells in the absence of Itk results in elevated IgE production","volume":"114","author":"Qi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.10.029_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","article-title":"Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk","volume":"228","author":"Readinger","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jid.2017.10.029_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajd.12294","article-title":"Biological therapies for psoriasis: adherence and outcome analysis from a clinical perspective","volume":"57","author":"Ross","year":"2016","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2017.10.029_bib33","doi-asserted-by":"crossref","unstructured":"Schwartzberg PL, Finkelstein LD, Readinger JA. TEC-Family Kinases: regulators of T-helper -cell differentiation. 2005;5:284\u201395.","DOI":"10.1038\/nri1591"},{"key":"10.1016\/j.jid.2017.10.029_bib34","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Sch\u00f6n","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7344","key":"10.1016\/j.jid.2017.10.029_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jid.2017.10.029_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T\u00a0cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2017.10.029_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.jid.2017.10.029_bib38","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.10.029_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0625.2010.01198.x","article-title":"Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases","volume":"20","author":"von Bonin","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2017.10.029_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1473-2165.2002.00406.x","article-title":"The Koebner phenomenon: review of the literature","volume":"16","author":"Weiss","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2017.10.029_bib42","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI85738","article-title":"Rac1 activation drives pathologic interactions between the epidermis and immune cells","volume":"126","author":"Winge","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2017.10.029_bib43","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.10.029_bib44","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1074\/jbc.M114.614891","article-title":"Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694","volume":"290","author":"Zhong","year":"2015","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17331457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17331457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T23:33:17Z","timestamp":1570318397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17331457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0022202X17331457"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.10.029","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}